Class 2 Recall - Water for injections 100ml x 25 vials

Hameln Pharma Ltd is recalling a batch of a product as a precautionary measure as remaining vials may no longer be in line with the licensed product specification.

MHRA drug alert link:

https://www.gov.uk/drug-device-alerts/class-2-medicines-recall-hameln-pharma-ltd-water-for-injections-bp-100ml-vial-el-22-a-06?utm_medium=email&utm_campaign=govuk-notifications-topic&utm_source=a0cd0c19-6da8-4f3e-b4c1-e3e2fde990d1&utm_content=immediately

Further Information

For more information or supply queries, please contact or email Hameln pharma ltd customer services on +44 (0)1452 621 661 or customer.services@hameln-pharma.co.uk

For medical information queries, please contact or email Hameln pharma ltd Medicines Information on +44 (0)1452 621 661 or drug.safety@hameln-pharma.co.uk

Please return all affected stock to your original supplier for credit. Unfortunately we can only accept stock purchased from us (Alliance Healthcare Distribution Limited). Any other stock will be returned to your stores/Pharmacies.

Please note that anything not returned to us, or notified to us, within 3 months of this notification, cannot be reimbursed by way of a credit.

If you have any questions, then please contact your local Service Centre Customer Services team.

Company Led Recall - Bucain Hyperbar 5mg/Ml Solution For Injection (Unlicensed Medicine)

Mawdsley-Brooks & Company Limited (UK importer) is recalling the above batch as a precautionary measure due out of specification result for pH that was identified during routine stability testing.

This product is supplied to hospital pharmacies only.

This recall is being issued as a company-led recall due to the limited number of packs distributed, and the UK importer has full traceability of the product’s onward distribution.

Remaining stock of the above batch should be quarantined and returned to the UK importer directly.

MHRA drug alert link:

https://www.gov.uk/drug-device-alerts/company-led-medicines-recall-bucain-hyperbar-5mg-slash-ml-solution-for-injection-unlicensed-medicine-clmr-22-a-slash-01?utm_medium=email&utm_campaign=govuk-notifications-topic&utm_source=59fedfa5-2201-4d43-9808-31e5d67cce88&utm_content=immediately

Alliance do not stock this product and therefore we are not accepting stock returns.

For more information please contact Charlotte Ray: charlotte.ray@mawdsleys.co.uk  or Tel: 07342 949 102

Lateral flow test – 04 February 2022 update

The PSNC reports: Pharmacy Collect - additional LFD stock still available

The UK Health Security Agency (UKHSA) are continuing to deliver stocks of lateral flow device (LFD) test kits to Alliance Healthcare for onward delivery to pharmacies.

Community pharmacy contractors requiring additional stocks of LFD test kits for their pharmacies can request up to three additional cartons of test kits by emailing the Pharmacy Collect team at pharmacy.collect.queries@dhsc.gov.uk. Requests should only be placed for pharmacies that are running out of their allocation within the day and are having to turn away customers. Contractors will need to provide the pharmacy name, address, ODS code, Alliance Healthcare customer account number and the number of cartons required up to a maximum of three cartons.

This order is in addition to the one carton daily order allowance that contractors can place through Alliance Healthcare. Orders will be dealt with on a first come, first served basis. The UKHSA will be working with Alliance Healthcare to fulfil these order requests and will supply Alliance Healthcare with a list of additional contractor orders each day. Alliance Healthcare will then process these orders and deliver them in line with their current delivery SLA with the UKHSA. Please note, this does not mean that contractors will receive the extra stock within three days of their email to the Pharmacy Collect Team.

The UKHSA has confirmed that they will review supplies on 11th February 2022 and work with PSNC to confirm and communicate if further additional orders can be accepted from contractors.

For the latest PIP codes please visit myahportal.com

Source: Pharmacy Collect: Additional LFD stock still available : PSNC Main site

Class 4 Drug Caution In Use - NAPROSYN TABLETS (ALL STRENGTHS), NAPROSYN EC 250MG GASTRO-RESISTANT TABLETS

Atnahs Pharma UK Limited have informed us that the Patient Information Leaflets (PILs) that have been provided with the below batches are missing information.

MHRA drug alert link:

https://www.gov.uk/drug-device-alerts/class-4-medicines-defect-information-atnahs-pharma-uk-limited-naprosyn-tablets-all-strengths-naprosyn-ec-250mg-gastro-resistant-tablets-el-22-a-slash-05?utm_medium=email&utm_campaign=govuk-notifications-topic&utm_source=8020daee-edf4-40b6-942b-a17672984fb1&utm_content=immediately

This is a caution in use only we are not accepting stock returns.

Further Information

For medical information queries or stock control queries, please contact: info@pharmanovia.com

If you have any questions, then please contact your local Service Centre Customer Services team. 

Class 4 Drug Caution In Use - IBUPROFEN 400MG TABLETS

Flamingo Pharma UK Ltd have identified an error relating to the embossed batch number on some cartons of Ibuprofen 400mg tablets. The batch number is illegible on some cartons and poses a risk to traceability in the event of a future recall or a medical enquiry. The batch numbers on the blisters within the cartons are clear and present. Additionally, the expiry date is still visible and clearly marked on the carton and blister.

MHRA drug alert link:

https://www.gov.uk/drug-device-alerts/class-4-medicines-defect-information-flamingo-pharma-uk-ltd-ibuprofen-400mg-tablets-el-22-a-slash-04?utm_medium=email&utm_campaign=govuk-notifications-topic&utm_source=4e98e5c4-603a-4941-8d14-a508d8879d6f&utm_content=immediately

Alliance healthcare do not stock this product therefore we are not accepting stock returns.

Further Information:

For medical information safety@flamingopharma.co.uk or general product enquiry sales@flamingopharma.co.uk +44 (0) 7733522465

Or

Mawdsley Brooks & Co Ltd

Overlabellingcustomerservices@mawdsleys.co.uk or 01302 553064

If you have any questions, then please contact your local Service Centre Customer Services team.

AmerisourceBergen launches its new ESG (Environmental, Social and Governance) microsite and FY21 report

Caring for our people, planet and the communities we serve is extremely important to our business.

This week, AmerisourceBergen launched its new ESG (Environmental, Social & Governance) report and microsite.

As part of AmerisourceBergen, we are delighted to be part of the global effort to create healthier futures.

Discover highlights here from Alliance Healthcare UK in this year's report and learn more about: Getting Drastic with Plastic, supporting the EORTC, Alloga Investors in People and supporting International Health Partners.

Class 4 Drug Caution in use - PIPERACILLIN/TAZOBACTAM 4 G/0.5G POWDER FOR SOLUTION FOR INFUSION

Antibiotice SA have identified an error on PIL of the below batches regarding the sodium content

MHRA drug alert link: https://www.gov.uk/drug-device-alerts/class-4-medicines-defect-information-antibiotice-sa-piperacillin-slash-tazobactam-4g-slash-0-dot-5-g-powder-for-solution-for-infusion-el-22-a-slash-03?utm_medium=email&utm_campaign=govuk-notifications-topic&utm_source=5c74d887-61f6-4a04-b8a1-a44bdd00e295&utm_content=immediately

Alliance healthcare do not stock this product therefore we are not accepting stock returns.

Further Information

For medical information please contact:

medical@antibiotice.ro

For stock control queries please contact:

shaunak@esteve.com

johnson@esteve.com

dromard@esteve.com

If you have any questions, then please contact your local Service Centre Customer Services team.

Lateral flow test – latest update

Latest information from Alliance Healthcare and UKHSA regarding lateral flow test distribution – 27 January

Alliance Healthcare continue to work with the UKHSA on the distribution of lateral flow tests to support the Pharmacy Collect scheme.

We recognise the challenging situation many pharmacy teams are facing to support the UK in the fight against COVID-19. Your dedication is truly appreciated, and we thank you for your patience during this period.

Demand for lateral flow tests has softened across the board; however, UK Health Security Agency (UKHSA) is supplying the Pharmacy Collect channel daily and over 10 million lateral flow tests are currently delivered to community pharmacies by Alliance Healthcare weekly.

Alliance Healthcare is in contact with UKHSA on a daily basis to obtain updates on supply to allow our Service Centres to plan for incoming stock consignments. There may be supply and logistical challenges for pharmacy deliveries which can affect any region at any time.

The UKHSA adds: “There are enough lateral flow tests for those who need them with 90m tests expected to be distributed each week for the next few weeks across all channels. Over 400m rapid tests are scheduled to be distributed across the UK in January.” The UKHSA and Alliance Healthcare continue to work together to increase the continuity of supply into pharmacy, develop the logistical options to deliver lateral flow devices to community pharmacy, this includes receiving deliveries at some Alliance Healthcare service centres on a Saturday, and receiving some stock directly from airports.

Further updates and PIP code information will be shared on the Alliance Healthcare Customer Portal (link: myahportal) and the Alliance Healthcare website.

Since the start of the Pharmacy Collect scheme, Alliance Healthcare has distributed over 265 million lateral flow tests to community pharmacy in the UK.

Class 4 Drug Caution in use - KABIVEN EMULSION FOR INFUSION

Fresenius Kabi Limited have identified an error in the infusion the infusion bag packaged into the below batches. In the list of ingredients section printed onto the bag, the amount of Glucose 19 %: Glucose (monohydrate) has been incorrectly declared as 110 g, the actual amount is 220g

MHRA drug alert link: https://www.gov.uk/drug-device-alerts/class-4-medicines-defect-information-fresenius-kabi-limited-kabiven-emulsion-for-infusion-el-22-a-slash-02?utm_medium=email&utm_campaign=govuk-notifications-topic&utm_source=a03ef0f0-48bd-41ad-81db-62dc0b48b245&utm_content=immediately     

Alliance healthcare do not stock this product therefore we are not accepting stock returns.

Further Information

For more information or medical information queries please contact: Medical.Information-UK@fresenius-kabi.com

If you have any questions, then please contact your local Service Centre Customer Services team.

CLASS 2 RECALL - IKERVIS EYE DROPS 0.1%

SANTEN Oy (trading as Santen UK Limited) are recalling the below batch of products as a precautionary measure due to detection of particles/crystals of the active pharmaceutical ingredient ciclosporin. These particles have been detected following microscopic evaluation during stability monitoring.

MHRA drug alert link: https://www.gov.uk/drug-device-alerts/class-2-medicines-recall-santen-oy-trading-as-santen-uk-limited-ikervis-1-mg-slash-ml-eye-drops-emulsion-el-22-a-slash-01?utm_medium=email&utm_campaign=govuk-notifications-topic&utm_source=9afe2758-9d36-4cbd-86c2-bef85307f4a5&utm_content=immediately     

Alliance do not stock the above products so we will not be accepting Customer returns on this recall.

Further Information

Santen UK Limited

For more information, please contact +44 (0)1727 615 110 or email enquiries@santen.co.uk

For medical information queries, please contact 0345 075 4863 or email medinfo@santen.co.uk

For supply queries, please contact AAH Customer services at 0344 561 8899

If you have any questions, then please contact your local Service Centre Customer Services team.